Milestone Scientific(US:MLSS)2025-11-14 14:32Financial Data and Key Metrics Changes - For Q3 2025, revenue was $2.4 million, a slight decrease from $2.5 million in Q3 2024. For the nine months ended September 30, 2025, revenue was $6.9 million, compared to $6.6 million for the same period in 2024 [10] - Operating expenses were reduced by over $500,000 compared to the same period last year, reflecting disciplined cost management [5][10] - As of September 30, 2025, cash and cash equivalents were approximately $1.3 million, with working capital of approximately $3.1 million [11] Business Line Data and Key Metrics Changes - In the dental segment, international sales increased year-over-year, partially offsetting a decline in domestic revenue [7] - Utilization of CompuFlow disposables rebounded slightly, indicating a re-engagement with current customers [7] Market Data and Key Metrics Changes - The company has a market share of approximately 1.5%-2% in both domestic and international markets, indicating significant room for growth [16] Company Strategy and Development Direction - The company is focused on three strategic priorities: streamlining operations, strengthening commercial execution in dental and medical sectors, and advancing reimbursement strategies for CompuFlow [6][12] - The addition of Dr. Dawood Syed to the board aims to enhance clinical and payer expertise, supporting the strategy for broader adoption within hospital systems [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's technology and the need for a structured approach to sales and reimbursement strategies [39][40] - The focus is on disciplined execution and operational excellence to build long-term shareholder value [12][50] Other Important Information - The company is enhancing its omnichannel marketing strategy to increase brand visibility and customer engagement [9] Q&A Session Summary Question: How to convince dental clinics to invest in new equipment? - Management acknowledged the need to reconnect with old customers and expand digital marketing efforts to raise awareness about the benefits of their products [15][16] Question: Update on the medical side and broader commercialization plans? - The company is focusing on a few jurisdictions for CompuFlow and plans to collect data meticulously to support Medicare reimbursement [21][22] Question: Impact of tariffs on supply chain and customer behavior? - Management reported minimal impact from tariffs and is considering a bonded warehouse in the U.S. to mitigate potential issues [29] Question: Structure of the salesforce and reimbursement specialists? - The company plans to ramp up its sales organization and is considering pursuing reimbursement codes for pediatric use [30][31] Question: Is there a seasonality pattern in sales? - Management indicated that the business is steady without significant seasonal fluctuations, expecting a similar performance in Q4 [32] Question: Long-term outlook and challenges faced? - Management emphasized the importance of having a structured approach to sales and reimbursement to ensure sustainable growth [39][40] Question: Current cash position and need for capital? - The company has sufficient cash to operate for several quarters and is looking for opportunities to improve its financial position [47]